155 related articles for article (PubMed ID: 37702096)
1. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic neuroendocrine neoplasms: Systematic review and meta-analysis.
Khoury T; Sbeit W; Fusaroli P; Campana D; Brighi N; Napoleon B; Lisotti A
Dig Endosc; 2024 Apr; 36(4):395-405. PubMed ID: 37702096
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Endoscopic Ultrasound-Guided Radiofrequency Ablation for Pancreatic Neuroendocrine Tumors: A Systematic Review and Metanalysis.
Armellini E; Facciorusso A; Crinò SF
Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837560
[No Abstract] [Full Text] [Related]
3. Efficacy and safety of endoscopic ultrasound-guided radiofrequency ablation for management of pancreatic lesions: a systematic review and meta-analysis.
Fahmawi Y; Mehta A; Abdalhadi H; Merritt L; Mizrahi M
Transl Gastroenterol Hepatol; 2022; 7():30. PubMed ID: 35892058
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of endoscopic ultrasound-guided ablation therapy for solid pancreatic tumors: a systematic review.
Zhang L; Tan S; Huang S; Zhong C; Lü M; Peng Y; Tang X
Scand J Gastroenterol; 2020 Sep; 55(9):1121-1131. PubMed ID: 32730715
[TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience.
Borrelli de Andreis F; Boškoski I; Mascagni P; Schepis T; Bianchi A; Schinzari G; Annicchiarico BE; Quero G; Tortora G; Alfieri S; Gasbarrini A; Costamagna G; Spada C; Attili F
Pancreatology; 2023 Aug; 23(5):543-549. PubMed ID: 37236853
[TBL] [Abstract][Full Text] [Related]
6. EUS-guided radiofrequency and ethanol ablation for pancreatic neuroendocrine tumors: A systematic review and meta-analysis.
Garg R; Mohammed A; Singh A; Harnegie MP; Rustagi T; Stevens T; Chahal P
Endosc Ultrasound; 2022; 11(3):170-185. PubMed ID: 35313416
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma.
Crinò SF; Napoleon B; Facciorusso A; Lakhtakia S; Borbath I; Caillol F; Do-Cong Pham K; Rizzatti G; Forti E; Palazzo L; Belle A; Vilmann P; van Laethem JL; Mohamadnejad M; Godat S; Hindryckx P; Benson A; Tacelli M; De Nucci G; Binda C; Kovacevic B; Jacob H; Partelli S; Falconi M; Salvia R; Landoni L; ; Larghi A
Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2834-2843.e2. PubMed ID: 36871765
[TBL] [Abstract][Full Text] [Related]
8. Endoscopic ultrasound guided radiofrequency ablation for pancreatic tumors: A critical review focusing on safety, efficacy and controversies.
Khoury T; Sbeit W; Napoléon B
World J Gastroenterol; 2023 Jan; 29(1):157-170. PubMed ID: 36683710
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic insulinoma: a state of the art review.
Dhar J; Samanta J; Nabi Z; Aggarwal M; Facciorusso A; Conti Bellocchi MC; Crinò SF
Expert Rev Gastroenterol Hepatol; 2024; 18(1-3):37-53. PubMed ID: 38383965
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic ultrasound-guided radiofrequency ablation of premalignant pancreatic-cystic neoplasms and neuroendocrine tumors: prospective study.
Younis F; Ben-Ami Shor D; Lubezky N; Geva R; Osher E; Shibolet O; Phillips A; Scapa E
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1111-1115. PubMed ID: 36170679
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of EUS-RFA in pancreatic tumors: Is it ready for prime time? A systematic review and meta-analysis.
Dhaliwal A; Kolli S; Dhindsa BS; Choa J; Mashiana HS; Ramai D; Chandan S; Bhogal N; Sayles H; Bhat I; Singh S; Adler DG
Endosc Int Open; 2020 Oct; 8(10):E1243-E1251. PubMed ID: 33015325
[No Abstract] [Full Text] [Related]
12. Endoscopic ultrasound-guided radiofrequency ablation of pancreatic microcystic serous cystic neoplasms: a retrospective study.
Oh D; Ko SW; Seo DW; Hong SM; Kim JH; Song TJ; Park DH; Lee SK; Kim MH
Endoscopy; 2021 Jul; 53(7):739-743. PubMed ID: 33063298
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic ablation therapy for the pancreatic neoplasms.
Matsumoto K; Kato H
Dig Endosc; 2023 May; 35(4):430-442. PubMed ID: 36366955
[TBL] [Abstract][Full Text] [Related]
14. EUS-guided Radiofrequency Ablation (EUS-RFA) of Solid Pancreatic Neoplasm Using an 18-gauge Needle Electrode: Feasibility, Safety, and Technical Success.
Crinò SF; D'Onofrio M; Bernardoni L; Frulloni L; Iannelli M; Malleo G; Paiella S; Larghi A; Gabbrielli A
J Gastrointestin Liver Dis; 2018 Mar; 27(1):67-72. PubMed ID: 29557417
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic ultrasound-guided ablation of solid pancreatic lesions: A systematic review of early outcomes with pooled analysis.
Spadaccini M; Di Leo M; Iannone A; von den Hoff D; Fugazza A; Galtieri PA; Pellegatta G; Maselli R; Anderloni A; Colombo M; Siersema PD; Carrara S; Repici A
World J Gastrointest Oncol; 2022 Feb; 14(2):533-542. PubMed ID: 35317325
[TBL] [Abstract][Full Text] [Related]
16. Study protocol for a multicenter randomized controlled trial to compare radiofrequency ablation with surgical resection for treatment of pancreatic insulinoma.
Crinò SF; Partelli S; Napoleon B; Conti Bellocchi MC; Facciorusso A; Salvia R; Forti E; Cintolo M; Mazzola M; Ferrari G; Carrara S; Repici A; Zerbi A; Lania A; Tacelli M; Arcidiacono PG; Falconi M; Larghi A; Rizzatti G; Alfieri S; Panzuto F; Hindryckx P; Berrevoet F; Lapauw B; Lakhtakia S; Sundaram S; Samanta J; Rastogi A; Landoni L
Dig Liver Dis; 2023 Sep; 55(9):1187-1193. PubMed ID: 37407318
[TBL] [Abstract][Full Text] [Related]
17. Management of non-functional pancreatic neuroendocrine tumors by endoscopic ultrasound-guided radiofrequency ablation: Retrospective study in two tertiary centers.
Marx M; Godat S; Caillol F; Poizat F; Ratone JP; Pesenti C; Schoepfer A; Hoibian S; Dahel Y; Giovannini M
Dig Endosc; 2022 Sep; 34(6):1207-1213. PubMed ID: 34963025
[TBL] [Abstract][Full Text] [Related]
18. Safety of endoscopic ultrasound-guided ethanol ablation for pancreatic cystic lesions: A single-center experience of 214 patients.
Choi JH; Lee SH; Choi YH; You MS; Shin BS; Paik WH; Ryu JK; Kim YT
Hepatobiliary Pancreat Dis Int; 2019 Dec; 18(6):562-568. PubMed ID: 31551143
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for EUS-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study).
Napoléon B; Lisotti A; Caillol F; Gasmi M; Ah-Soune P; Belle A; Charachon A; Cholet F; Eyraud PY; Grandval P; Gonzalez JM; Habersetzer F; Koch S; Le Rhun M; Mangialavori L; Musquer N; Palazzo M; Poincloux L; Privat J; Sportes A; Stouvenot M; Subtil C; Thomassin L; Vanbiervliet G; Vidal G; Vuitton L; Giovannini M; Barthet M
Gastrointest Endosc; 2023 Sep; 98(3):392-399.e1. PubMed ID: 37059368
[TBL] [Abstract][Full Text] [Related]
20. Utility of Contrast-Enhanced Harmonic Endoscopic Ultrasound for the Guidance and Monitoring of Endoscopic Radiofrequency Ablation.
Choi JH; Seo DW; Song TJ; Park DH; Lee SS; Lee SK; Kim MH
Gut Liver; 2020 Nov; 14(6):826-832. PubMed ID: 32000466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
